advisorsecurities master

PALIPalisade Bio, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
19843
Ticker
PALI
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2021-04-28
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
PALI

Detail

Enriched 2026-08-14 20:47

Market cap
$341,570,293.68
Shares outstanding (class)
173,579,670
Shares outstanding (weighted)
174,270,558
SIC
2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
14
Location
CARLSBAD, CA
Description

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data